Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06934499

Tunisian Lung Cancer Study

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tunisian Society of Medical Oncology, Aryanah, Tunisia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age more than 18 years
  • Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
  • Informed consent

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Diagnostic delay

    Time frame: Day 1

    Delay to set the pulmonary cancer diagnosis

  2. Survival

    Time frame: 12 months

    Overall survival

  3. Relapse

    Time frame: 12 months

    Time to relapse

Secondary outcomes

  1. Recommendation Compliance

    Time frame: Day 1

    Compliance to national and international guidance of pulmonary cancer management

Other outcomes

  1. Multidisciplinary Consultation Meetings

    Time frame: 12 months

    Number of Multidisciplinary Consultation Meetings

Study contacts

Contact information is provided by the study sponsor or research team.

Nesrine Mejri, MD

CONTACT

[email protected]

+216 97 429 933

Soraya Fenniche, MD

CONTACT

[email protected]

+216 98 586 490

Sponsors and collaborators

Lead sponsor

Dacima Consulting

Other

Collaborators

  • The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
  • Tunisian Society of Medical Oncology
  • Tunisian Society of Respiratory Diseases and Allergology

Registry information

Official study title

Clinical Observational Study on Tunisian Lung Cancer

Acronym: LUNG-TUN

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 18, 2025
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.